TO: The Gustavus Community
FROM: COVID-19 Response Leadership Team
SUBJECT: COVID-19 Weekly Update
DATE: April 13, 2021
WEEKLY TIP
Today, the Centers for Disease Control & Prevention (CDC and FDA (Food & Drug Administration) recommended temporarily pausing further administration of the Janssen (Johnson & Johnson) vaccine out of an abundance of caution. Please see the joint release from the two organizations for more details.
While the incidents leading to the temporary pause of the J&J vaccine have been extremely rare, anyone who has received the J&J vaccine who develops severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact the Gustavus Health Service or your own health care provider.
We continue to strongly encourage everyone in our community to get vaccinated. Please check our Gustavus Vaccine Resources website for more information about where to find vaccines. If you have already received your vaccine, you can register to receive personalized health check-ins via your phone once you have received the vaccine at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafe.html.
COVID-19 DASHBOARD UPDATE
As of April 12, 2021
As of April 12, 2021
Total Positive Cases (since August 15): 290
Current Positive Student Cases: 12
Current Positive Employee Cases: 0
Total Students in Isolation/Quarantine: 30
Students in Isolation/Quarantine On Campus: 14
Employees in Isolation/Quarantine: 4
This data set is meant to encompass the on-campus impact of COVID-19 by counting cases where a person may have been on campus while infectious. For example, students who are living at home or employees who are working remotely and not visiting campus will not be counted in these on-campus numbers. This information is also available for viewing on the College’s COVID-19 Dashboard.
As always, if you have any questions, please consult the College’s COVID-19 website and email g-covidresponse@gustavus.edu.
Leave a Reply